OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 25.55
-0.75 (-2.85%)
Jul 29, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 3.36 billion as of July 29, 2026. Its market cap has decreased by -61.84% in one year.
Market Cap
3.36B
Enterprise Value
3.80B
Revenue
49.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.55
ChartMarket Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 3.36B, a decrease of -80.07%. That is a compound annual growth rate of -11.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.36B | -52.65% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.77B |
| Genovate Biotechnology | 3.65B |
| Senhwa Biosciences | 3.52B |
| BioGend Therapeutics | 3.27B |
| Great Novel Therapeutics Biotech & Medicals | 3.23B |
| Sagittarius Life Science | 3.21B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Apex Biotechnology | 3.17B |